[New development on the field of antibiotic therapy].
D000617:Aminoglycosides / Q000494:pharmacology; D000658:Amoxicillin / Q000097:blood; D000667:Ampicillin / Q000097:blood; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002228:Carbenicillin; D002511:Cephalosporins / Q000494:pharmacology; D003493:Cyclacillin; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D010403:Penicillin Resistance; D010917:Pivampicillin; D011513:Proteus mirabilis / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects; D013982:Ticarcillin
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010917:Pivampicillin; D003493:Cyclacillin; D000667:Ampicillin; D000658:Amoxicillin; D013982:Ticarcillin; D002228:Carbenicillin
Neue Entwicklungen auf dem Gebiet der Antibiotica-Therapie